Study Methods (Part 2)
The second part of the study involved a comprehensive screening of a wider range of TXA injection products collected from the E-MOTIVE implementation sites in Kenya, Nigeria, South Africa and Tanzania. Compatibility was assessed against two OXY injection products used at the trial sites.